Overexpression of RSPO2, specifically in ingWAT, confirmed our finding that RSPO2 can inhibit adipocyte formation and cause adipocyte hypertrophy, with a trend toward development of insulin resistance. Here, RSPO2 is linked to Insulin resistance.